Dr. Geeta Devgan

Dr. Geeta Devgan

Prostate Cancer Team Lead US Medical Affairs

Prostate Cancer Team Lead US Medical Affairs

Pfizer

Geeta Devgan, PhD is the US Medical Affairs Franchise Team Lead for Prostate Cancer at Pfizer. She has over 15 years of oncology experience in multiple cross-functional medical leadership roles, across solid tumors and hematologic malignancies, focused on developing and executing medical strategies at all stages of a product’s lifecycle.  Geeta earned her Ph.D. in Molecular, Cellular & Developmental Biology at Yale University with a focus on understanding kinase signaling pathways with protein microarray technology.  She also conducted postdoctoral research on serum peptide patterns in cancer patients using mass spectrometry at Memorial Sloan-Kettering Cancer Center.

Mr. and Mrs. Charles Seabrook

Mr. and Mrs. Charles Seabrook

Prostate Cancer Survivor and his Wife

Prostate Cancer Survivor and his Wife

Charles and Cherry Seabrook have been married for 62 years. They are retired and reside in Charleston, South Carolina. Cherry is a six-year breast cancer survivor and former nurse. She is also a volunteer board member at Hollings Cancer Center Disparities Board in Charleston, SC. Charles is a newly diagnosed prostate cancer patient. They are caregivers to each other as well as their families.

Mr. Micah Christian

Mr. Micah Christian

Caregiver, Son of Chuck Christian

Caregiver, Son of Chuck Christian

Professional Musician, Sons of Serendip

Micah Christian, a native of Randolph, Massachusetts, became interested in music at an early age. However, it wasn’t until his senior year of high school, when he earned a solo in the Massachusetts Southeastern District Senior Choir, that he realized his potential as a musician. As a freshman at Stonehill College, he decided to follow his passion for music. For the next five years, he spent his summers performing with the Cape Cod-based a cappella group, Hyannis Sound, and his love for music deepened.  Alongside Micah’s passion for music is his desire to help build a better world. He has volunteered for a year in Honduras, and a month in Calcutta, India with Mother Teresa’s Missionaries of Charity. Also, in 2013, after graduating from Boston University with a Master of Divinity, he and his wife volunteered in a rural community in northern Peru for another year. As a member of Sons of Serendip, Micah hopes to inspire others to use their gifts to spread love and build a better world.

Dr. Andrew J. Roth

Dr. Andrew J. Roth

Emeritus Attending Psychiatrist

Emeritus Attending Psychiatrist

Memorial Sloan Kettering Cancer Center

Andrew Roth, MD, is an Emeritus Member of the Psychiatry Service, Department of Psychiatry & Behavioral Sciences, at Memorial Sloan Kettering Cancer Center (MSK).

Dr. Roth became a clinical fellow in Psycho-Oncology/Consultation-Liaison Psychiatry on the Psychiatry Service at MSK in 1992 after graduating from Mt. Sinai Medical Center’s Psychiatry Residency Program. He joined MSK’s attending staff in 1994, where he served as clinical member and attending psychiatrist through 2022. Dr. Roth concurrently worked as a professor of Clinical Psychiatry at Weill Cornell Medical College (WCMC), Department of Psychiatry, and as an attending psychiatrist at New York-Presbyterian Hospital (NYPH).

In 2023, Dr. Roth was appointed to the Emeritus faculty at Memorial Hospital for Cancer and Allied Diseases, Department of Psychiatry & Behavioral Sciences, NYPH’s Department of Psychiatry, and Professor Emeritus of Clinical Psychiatry at WCMC, Cornell University.

Through 2019, Dr. Roth served as both assistant program director and program director for MSK’s ACGME- accredited Psychosomatic Medicine/Psycho-Oncology Clinical Fellowship Training Program. Dr. Roth helped train close to 150 psychiatrists in the subspecialty of psycho-oncology, receiving awards for clinical and teaching excellence.

He also served as the psychiatry liaison to genitourinary medical oncology at MSK for over 28 years. His research includes the development of the distress thermometer; the creation of the Memorial Anxiety Scale for Prostate Cancer (MAX-PC); a National Cancer Institute-funded, double-blind, randomized control trial using methylphenidate for fatigue in men with prostate cancer; and most recently, evaluation of a novel psychotherapy designed specifically for older cancer patients. He also helped start the Psychiatry Clinical Service at the MSK Westchester.

Dr. Robert Bridwell

Dr. Robert Bridwell

Medical Advisor

Medical Advisor

Sophie Co

Dr. Robert S. Bridwell is a Medical Advisor at SOFIE Co. and the Founder and Chief Medical Officer at Appian 360. He is also the Founder and CMO of Bridwell Consulting Services. He has worked as a Medical Director at Medical Outsourcing Services, LLC and has a background as Chief of Nuclear Medicine for the Walter Reed Army Medical Center.

Dr. Bridwell obtained a Bachelor of Arts degree in Biophysics from the University of California at Berkeley. He received his medical degree from the Uniformed Services University of the Health Sciences in Bethesda, Maryland and his MBA from Regis University in Denver, Colorado.

Dr. Bridwell is a member of the Society of Nuclear Medicine & Molecular Imaging as well as the European Society of Nuclear Medicine. He was also awarded the Army Commendation Medal in 1998, the Army Achievement Medal in 1999, and another Army Commendation Medal in 2000.

Dr. Alessandra Cesano

Dr. Alessandra Cesano

Chief Medical Officer, Executive Vice President

Chief Medical Officer, Executive Vice President

Essa Pharma

Dr. Alessandra Cesano has been ESSA’s Chief Medical Officer since 2019 and Executive Vice President since 2023. Prior to joining ESSA, Dr. Cesano served as Chief Medical Officer at NanoString Inc., focusing on the development of translational and diagnostic multi-plexed assays for the characterization and measurement of mechanisms of immune response and resistance. Previously, Dr. Cesano was the Chief Medical Officer at Cleave Biosciences, Inc., and Nodality, Inc. Throughout her career, Dr. Cesano has held various management positions at Amgen, Biogen Idec and SmithKline Beecham Pharmaceuticals, where she helped advance various oncology drugs through late-stage development and FDA approvals. Early in her professional career, Dr. Cesano spent 12 years conducting research in tumor immunology, including nine years at the Wistar Institute, an NCI Basic Cancer Center connected with the University of Pennsylvania, and she has authored over 100 publications. Dr. Cesano received an M.D. summa cum laude, a Board Certification in Oncology and a Ph.D. in Tumor Immunology from the University of Turin